The Canadian Biomarker Integration Network in Depression (CAN-BIND) is a national program of research and learning. Our community includes persons with lived experience, caregivers, researchers, healthcare providers, government agencies, industry partners, and mental health advocates who are working together to achieve mental wellness for all Canadians. CAN-BIND is discovering ways to identify the right treatment for the right person in order to help individuals with depression get well quickly, and stay well. Our Vision: Improving depression care together through education, innovation and practice. Our Mission: Our mission is to deliver fast and effective care to all Canadians living with depression. Through collaboration, research innovation and systems-oriented thinking, we seek to discover treatment strategies guided by each individual’s comprehensive history and pathway to depression.
| Website | http://www.canbind.ca |
| Employees | 14 (4 on RocketReach) |
| Founded | 2011 |
| Address | 193 Yonge Street, Toronto, Ontario M5B 1M4, CA |
| Technologies |
JavaScript
,
HTML
,
PHP
+14 more
(view full list)
|
| Industry | Hospitals and Health Care |
| Keywords | Depression Research, Mental Health Research, Biomarker Research, Biomarker Discovery, Healthcare Research, Clinical Research, Depression Treatment, Mental Health Network, Data Integration, Research Collaboration, Patient Advocacy, Caregiver Support, Healthcare Innovation, Mental Health Care, Psychiatric Research, Biomedical Research, Psychological Research, Public Health Research |
| Competitors | Pfizer, Bristol Myers Squibb, AstraZeneca, Novartis, AbbVie, Johnson & Johnson, Sanofi, GSK, Merck AH, Lilly India +32 more (view full list) |
Looking for a particular CAN-BIND Depression Network employee's phone or email?
4 people are employed at CAN-BIND Depression Network.
CAN-BIND Depression Network is based in Toronto, Ontario.